The prognostic value of cardiopulmonary exercise testing in idiopathic pulmonary fibrosis

American Journal of Respiratory and Critical Care Medicine

Volumn 179, Issue 5, 2009, Pages 402-407

  Fell, Charlene D ^a   Liu, Lyrica Xiaohong ^b   Motika, Caroline ^c   Kazerooni, Ella A ^d   Gross, Barry H ^d   Travis, William D ^f   Colby, Thomas V ^g   Murray, Susan ^b   Toews, Galen B ^e   Martinez, Fernando J ^e   Flaherty, Kevin R ^e,h  

^a UNIVERSITY OF CALGARY   (Canada)

^b UNIVERSITY OF MICHIGAN   (United States)

^c UNIVERSITY OF CHICAGO   (United States)

^d Department of Radiology

^e UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

^f MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^g MAYO CLINIC   (United States)

^h UNIVERSITY OF MICHIGAN   (United States)

Author keywords

Exercise test; Idiopathic pulmonary fibrosis; Mortality

Indexed keywords

AGED; ARTICLE; CARDIOPULMONARY EXERCISE TEST; CONTROLLED STUDY; FIBROSING ALVEOLITIS; HUMAN; HUMAN TISSUE; LUNG BIOPSY; LUNG FUNCTION TEST; MAJOR CLINICAL STUDY; MORTALITY; OXYGEN CONSUMPTION; PRIORITY JOURNAL; PROGNOSIS; SCHOOL CHILD; SURVIVAL RATE; EXERCISE TEST; EXERCISE TOLERANCE; FEMALE; KAPLAN MEIER METHOD; LUNG FIBROSIS; MALE; METABOLISM; MIDDLE AGED; PHYSIOLOGY; PREDICTION AND FORECASTING; PROPORTIONAL HAZARDS MODEL; RETROSPECTIVE STUDY; SMOKING; STATISTICAL MODEL;

OXYGEN;

AGED; EXERCISE TEST; EXERCISE TOLERANCE; FEMALE; HUMANS; KAPLAN-MEIERS ESTIMATE; LOGISTIC MODELS; MALE; MIDDLE AGED; OXYGEN; OXYGEN CONSUMPTION; PREDICTIVE VALUE OF TESTS; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; PULMONARY FIBROSIS; RETROSPECTIVE STUDIES; SMOKING;

EID: 63349091740     PISSN: 1073449X     EISSN: 15354970     Source Type: Journal    
DOI: 10.1164/rccm.200802-241OC     Document Type: Article

References (41)

1. King TE Jr, Costabel U, Cordier J-F, DoPico GA, du Bois RM, Lynch D, Lynch JP, Myers J, Panos R, Raghu G, et al. Idiopathic pulmonary fibrosis: diagnosis and treatment. International consensus statement. Am J Respir Crit Care Med 2000;161:646-664.
2. Martinez FJ, Safrin S, Weycker D, Starko KM, Bradford WZ, King TE Jr, Flaherty KR, Schwartz DA, Noble PW, Raghu G, et al. The clinical course of patients with idiopathic pulmonary fibrosis. Ann Intern Med 2005;142:963-967.
3. Hubbard R, Johnston I, Britton J. Survival in patients with cryptogenic fibrosing alveolitis: a population-based cohort study. Chest 1998;113:396-400.
4. King T Jr, Schwarz M, Brown K, Tooze J, Colby T, Waldron J Jr, Flint A, Thurlbeck W, Cherniack R. Idiopathic pulmonary fibrosis: Relationship between histopathologic features and mortality. Am J Respir Crit Care Med 2001;164:1025-1032.
5. King T Jr, Tooze J, Schwarz M, Brown K, Cherniack R. Predicting survival in idiopathic pulmonary fibrosis: scoring system and survival model. Am J Respir Crit Care Med 2001;164:1171-1181.
6. Flaherty K, Toews G, Travis W, Colby T, Kazerooni E, Gross B, Jain A, Strawderman R III, Paine R III, Flint A, et al. Clinical significance of histological classification of idiopathic interstitial pneumonia. Eur Respir J 2002;19:275-283.
7. Lama VN, Flaherty KR, Toews GB, Colby TV, Travis WD, Long Q, Murray S, Kazerooni EA, Gross BH, Lynch JP III, et al.Prognostic value of desaturation during a 6-minute walk test in idiopathic interstitial pneumonia. Am J Respir Crit Care Med 2003;168:1084-1090.
8. Mogulkoc N, Brutsche MH, Bishop PW, Greaves SM, Horrocks AW, Egan JJ, Consortium GMPF. Pulmonary function in idiopathic pulmonary fibrosis and referral for lung transplantation. Am J Respir Crit Care Med 2001;164:103-108.
9. Hallstrand TS, Boitano LJ, Johnson WC, Spada CA, Hayes JG, Raghu G. The timed walk test as a measure of severity and survival in idiopathic pulmonary fibrosis. Eur Respir J 2005;25:96-103.
10. Eaton T, Young P, Milne D, Wells AU. Six-minute walk, maximal exercise tests: reproducibility in fibrotic interstitial pneumonia. Am J Respir Crit Care Med 2005;171:1150-1157.
11. Jegal Y, Kim DS, Shim TS, Lim CM, Do Lee S, Koh Y, Kim WS, Kim WD, Lee JS, Travis WD, et al. Physiology is a stronger predictor of survival than pathology in fibrotic interstitial pneumonia. Am J Respir Crit Care Med 2005;171:639-644.
12. Latsi PI, du Bois RM, Nicholson AG, Colby TV, Bisirtzoglou D, Nikolakopoulou A, Veeraraghavan S, Hansell DM, Wells AU. Fibrotic idiopathic interstitial pneumonia: the prognostic value of longitudinal functional trends. Am J Respir Crit Care Med 2003;168:531-537.
13. Collard H, King T, Bartelson B, Vourlekis J, Schwarz M, Brown K. Changes in clinical and physiologic variables predict survival in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 2003;168:538-542.
14. Flaherty K, Mumford J, Murray S, Kazerooni E, Gross B, Colby T, Travis W, Flint A, Toews G, Lynch J, et al. Prognostic implications of physiologic and radiographic changes in idiopathic interstitial pneumonia. Am J Respir Crit Care Med 2003;168:543-548.
15. Flaherty KR, Andrei A-C, Murray S, Fraley C, Colby TV, Travis WD, Lama V, Kazerooni EA, Gross BH, Toews GB, et al. Idiopathic pulmonary fibrosis: prognostic value of changes in physiology and six minute hallwalk. Am J Resp Crit Care Med 2006;174:803-809.
16. Lama VN, Martinez FJ. Resting and exercise physiology in interstitial lung diseases. Clin Chest Med 2004;25:435-453.
17. Agusti AG, Roca J, Rodriguez-Roisin R, Xaubet A, Agusti-Vidal A. Different patterns of gas exchange response to exercise in asbestosis and idiopathic pulmonary fibrosis. Eur Respir J 1988;1:510-516.
18. Gay SE, Kazerooni EA, Toews GB, Lynch JP III, Gross BH, Cascade PN, Spizarny DL, Flint A, Schork MA, Whyte RI, et al. Idiopathic pulmonary fibrosis: predicting response to therapy and survival. Am J Respir Crit Care Med 1998;157:1063-1072.
19. Erbes R, Schaberg T, Loddenkemper R. Lung function tests in patients with idiopathic pulmonary fibrosis: are they helpful for predicting outcome? Chest 1997;111:51-57.
20. Hansen JE, Wasserman K. Pathophysiology of activity limitation in patients with interstitial lung disease. Chest 1996;109:1566-1576.
21. American Thoracic Society/American College of Chest Physicians. ATS/ACCP statement on cardiopulmonary exercise testing. Am J Respir Crit Care Med 2003;167:211-277.
22. King TE Jr, Safrin S, Starko KM, Brown KK, Noble PW, Raghu G, Schwartz DA. Analyses of efficacy end points in a controlled trial of interferon-gamma1b for idiopathic pulmonary fibrosis. Chest 2005;127:171-177.
23. Lynch DA, David Godwin J, Safrin S, Starko KM, Hormel P, Brown KK, Raghu G, King TE Jr, Bradford WZ, Schwartz DA, et al.High-resolution computed tomography in idiopathic pulmonary fibrosis: diagnosis and prognosis. Am J Respir Crit Care Med 2005;172:488-493.
24. Hunninghake G, Zimmerman M, Schwartz D, King T Jr, Lynch J, Hegele R, Waldron J, Colby T, Muller N, Lynch D, et al. Utility of a lung biopsy for the diagnosis of idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 2001;164:193-196.
25. Flaherty K, Thwaite E, Kazerooni E, Gross B, Toews G, Colby T, Travis W, Mumford J, Murray S, Flint A, et al. Radiological versus histological diagnosis in UIP and NSIP: survival implications. Thorax 2003;58:143-148.
26. Fraley C, Martinez F, Lama V, Colby T, Travis W, Toews G, Flint A, Chang A, Flaherty K. Distance walking during a six minute walk test (6MWT) relative to the quantity of desaturation predicts mortality in patients with idiopathic pulmonary fibrosis (IPF). Proc Am Thorac Soc 2005;2:A316.
27. Social Security Death Index (SSDI) Interactive Search [Internet]. Provo, UT: The Generations Network, Inc. c1998-[updated 2008 Dec 23; accessed 2008 Dec 22]. Available from: http://ssdi.rootsweb.ancestry.com. (SSDI is generated from the U.S. Social Security Administration's Death Master File.)
28. Cox D. Regression models and life tables (with discussion). J R Stat Soc [Ser A] 1972;B34:187-220.
29. Gosset WSS. The probable error of a mean. Biometrika 1908;6:1-25.
30. K. Pearson. On the criterion that a given system of deviations from the probable in the case of a correlated system of variables is such that it can be reasonably supposed to have arisen from random sampling. Philosophical Magazine, Series 5 1900;50:157-175.
31. Harrell FE Jr, Lee KL, Mark DB. Multivariable prognostic models: issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors. Stat Med 1996;15:361-387.
32. Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958;53:457-481.
33. Savage IR. Contributions to the theory of rank-order statistics - the two sample case. Ann Math Stat 1956;27:590-615.
34. Mantel N. Evaluation of survival data and two new rank-order statistics arising in its consideration. Cancer Chemother Rep 1966;50:163-170.
35. Wensel R, Opitz CF, Anker SD, Winkler J, Hoffken G, Kleber FX, Sharma R, Hummel M, Hetzer R, Ewert R. Assessment of survival in patients with primary pulmonary hypertension: importance of cardiopulmonary exercise testing. Circulation 2002;106:319-324.
36. Watters L, King T, Schwarz M, Waldron J, Stanford R, Cherniack R. A clinical, radiographic, and physiologic scoring system for the longitudinal assessment of patients with idiopathic pulmonary fibrosis. Am Rev Respir Dis 1986;133:97-103.
37. Miki K, Maekura R, Hiraga T, Okuda Y, Okamoto T, Hirotani A, Ogura T. Impairments and prognostic factors for survival in patients with idiopathic pulmonary fibrosis. Respir Med 2003;97:482-490.
38. Lettieri CJ, Nathan SD, Barnett SD, Ahmad S, Shorr AF. Prevalence and outcomes of pulmonary arterial hypertension in advanced idiopathic pulmonary fibrosis. Chest 2006;129:746-752.
39. Nadrous HF, Pellikka PA, Krowka MJ, Swanson KL, Chaowalit N, Decker PA, Ryu JH. Pulmonary hypertension in patients with idiopathic pulmonary fibrosis. Chest 2005;128:2393-2399.
40. Hamada K, Nagai S, Tanaka S, Handa T, Shigematsu M, Nagao T, Mishima M, Kitaichi M, Izumi T. Significance of pulmonary arterial pressure and diffusion capacity of the lung as prognosticator in patients with idiopathic pulmonary fibrosis. Chest 2007;131:650-656.
41. Flaherty KR, Brewer GJ, Andrei A, Murray S, Toews GB, Martinez FJ. A phase I/II trial of tetrathiomolybdate for patients with idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 2007;175:A497.